SCHEMBL6269488

SCHEMBL6269488

COc1cc2nc(N(Cl)c3ccc(F)cc3)ncc2cc1OCCCN(C)C

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 3/20 0.42
▸ PDGFRB P09619 2/20 0.40
▸ PDGFRA P16234 2/20 0.40
▸ PDPK1 O15530 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ RET P07949 1/20 0.39
▸ KIF5B P33176 1/20 0.39
▸ QPCT Q16769 2/20 0.38
▸ AXL P30530 1/20 0.38
▸ TLR9 Q9NR96 1/20 0.38
▸ TLR7 Q9NYK1 1/20 0.38
▸ ATM Q13315 1/20 0.37
▸ EHMT2 Q96KQ7 2/20 0.36
▸ EHMT1 Q9H9B1 1/20 0.36
▸ DNMT1 P26358 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6266311 0.90 EGFR (0.44) EGFRPDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL6268116 0.84 EHMT2 (0.57) TLR9TLR7EHMT2EHMT1DNMT1
SCHEMBL8438071 0.83 KDR (0.38) EGFRPDGFRBPDGFRAKDM4EALDH1A1
SCHEMBL5618725 0.82 EHMT2 (0.51) EGFRTLR9TLR7EHMT2EHMT1
SCHEMBL8436900 0.82 EPHA2 (0.42) PDGFRBPDGFRAKDM4EALDH1A1SMN1; SMN2
SCHEMBL3727488 0.81 EGFR (0.49) EGFRRETAXLTLR9TLR7
SCHEMBL6266570 0.80 EGFR (0.46) EGFRPDPK1RETQPCTEHMT2
SCHEMBL8444662 0.80 EPHA2 (0.44) PDGFRBPDGFRAKDM4EALDH1A1SMN1; SMN2
SCHEMBL6266172 0.80 EGFR (0.46) EGFRPDGFRBKDM4EALDH1A1QPCT
SCHEMBL11424 0.79 PDGFRB (0.40) EGFRPDGFRBPDGFRAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005048928-A2 METHODS FOR TREATING VIRAL INFECTION GEORGE MASON INTELLECTUAL PROPERTY (US) 2005-06-02 — — WO disclosed
Send feedback